These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36225647)

  • 1. A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancer.
    Ko S; Jung KH; Yoon YC; Han BS; Park MS; Lee YJ; Kim SE; Cho YJ; Lee P; Lim JH; Ryu JK; Kim K; Kim TY; Hong S; Lee SH; Hong SS
    Am J Cancer Res; 2022; 12(9):4326-4342. PubMed ID: 36225647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer.
    Lee JE; Lee P; Yoon YC; Han BS; Ko S; Park MS; Lee YJ; Kim SE; Cho YJ; Lim JH; Ryu JK; Shim S; Kim DK; Jung KH; Hong SS
    Biomed Pharmacother; 2023 Jun; 162():114716. PubMed ID: 37086509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma.
    Aguilera KY; Huang H; Du W; Hagopian MM; Wang Z; Hinz S; Hwang TH; Wang H; Fleming JB; Castrillon DH; Ren X; Ding K; Brekken RA
    Mol Cancer Ther; 2017 Nov; 16(11):2473-2485. PubMed ID: 28864681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer.
    Jung KH; Choi IK; Lee HS; Yan HH; Son MK; Ahn HM; Hong J; Yun CO; Hong SS
    Cancer Lett; 2017 Jun; 396():155-166. PubMed ID: 28315430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of DDR1/PYK2/ERK signaling suggesting SH2 superbinder as a novel autophagy inhibitor for pancreatic cancer.
    Xu H; Tan M; Hou GQ; Sang YZ; Lin L; Gan XC; Cao X; Liu AD
    Cell Death Dis; 2023 Dec; 14(12):811. PubMed ID: 38071340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis.
    Deng J; Kang Y; Cheng CC; Li X; Dai B; Katz MH; Men T; Kim MP; Koay EA; Huang H; Brekken RA; Fleming JB
    JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34237033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.
    Huang H; Svoboda RA; Lazenby AJ; Saowapa J; Chaika N; Ding K; Wheelock MJ; Johnson KR
    J Biol Chem; 2016 Oct; 291(44):23208-23223. PubMed ID: 27605668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming the Tumor Collagen Barriers: A Multistage Drug Delivery Strategy for DDR1-Mediated Resistant Colorectal Cancer Therapy.
    Cui G; Deng S; Zhang B; Wang M; Lin Z; Lan X; Li Z; Yao G; Yu M; Yan J
    Adv Sci (Weinh); 2024 Sep; 11(33):e2402107. PubMed ID: 38953306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome.
    Su H; Yang F; Fu R; Trinh B; Sun N; Liu J; Kumar A; Baglieri J; Siruno J; Le M; Li Y; Dozier S; Nair A; Filliol A; Sinchai N; Rosenthal SB; Santini J; Metallo CM; Molina A; Schwabe RF; Lowy AM; Brenner D; Sun B; Karin M
    Nature; 2022 Oct; 610(7931):366-372. PubMed ID: 36198801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDR1 and MT1-MMP Expression Levels Are Determinant for Triggering BIK-Mediated Apoptosis by 3D Type I Collagen Matrix in Invasive Basal-Like Breast Carcinoma Cells.
    Saby C; Collin G; Sinane M; Buache E; Van Gulick L; Saltel F; Maquoi E; Morjani H
    Front Pharmacol; 2019; 10():462. PubMed ID: 31130862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discoidin Domain Receptor 1 (DDR1) Is Necessary for Tissue Homeostasis in Pancreatic Injury and Pathogenesis of Pancreatic Ductal Adenocarcinoma.
    Ruggeri JM; Franco-Barraza J; Sohail A; Zhang Y; Long D; Pasca di Magliano M; Cukierman E; Fridman R; Crawford HC
    Am J Pathol; 2020 Aug; 190(8):1735-1751. PubMed ID: 32339496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines.
    Azizi R; Fallahian F; Aghaei M; Salemi Z
    Anticancer Agents Med Chem; 2020; 20(8):1009-1016. PubMed ID: 32275493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition.
    Miao L; Zhu S; Wang Y; Li Y; Ding J; Dai J; Cai H; Zhang D; Song Y
    Med Oncol; 2013; 30(3):626. PubMed ID: 23761027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines.
    Azizi R; Salemi Z; Fallahian F; Aghaei M
    J Cell Physiol; 2019 Nov; 234(11):19539-19552. PubMed ID: 30963567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic Ad co-expressing decorin and Wnt decoy receptor overcomes chemoresistance of desmoplastic tumor through degradation of ECM and inhibition of EMT.
    Li Y; Hong J; Jung BK; Oh E; Yun CO
    Cancer Lett; 2019 Sep; 459():15-29. PubMed ID: 31150821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice.
    Sun X; Gupta K; Wu B; Zhang D; Yuan B; Zhang X; Chiang HC; Zhang C; Curiel TJ; Bendeck MP; Hursting S; Hu Y; Li R
    J Biol Chem; 2018 Feb; 293(8):2841-2849. PubMed ID: 29298894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
    Begum A; Ewachiw T; Jung C; Huang A; Norberg KJ; Marchionni L; McMillan R; Penchev V; Rajeshkumar NV; Maitra A; Wood L; Wang C; Wolfgang C; DeJesus-Acosta A; Laheru D; Shapiro IM; Padval M; Pachter JA; Weaver DT; Rasheed ZA; Matsui W
    PLoS One; 2017; 12(7):e0180181. PubMed ID: 28692661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo.
    Chen YH; Chen YC; Lin CC; Hsieh YP; Hsu CS; Hsieh MC
    Cancer Manag Res; 2020; 12():4645-4665. PubMed ID: 32606957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.
    Hur H; Ham IH; Lee D; Jin H; Aguilera KY; Oh HJ; Han SU; Kwon JE; Kim YB; Ding K; Brekken RA
    BMC Cancer; 2017 Jan; 17(1):87. PubMed ID: 28143619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1.
    Ali-Rahmani F; FitzGerald DJ; Martin S; Patel P; Prunotto M; Ormanoglu P; Thomas C; Pastan I
    Cancer Res; 2016 Mar; 76(6):1560-8. PubMed ID: 26719540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.